UNAIDs JUNPoHA. Global AIDs update 2020. 20 Avenue Appia, 1211 Geneva 27, Switzerland; 2020.
UNAIDS. Factsheet: global AIDS update. 2019. UNAIDS Geneva: 2019. Geneva; 2019.
Organization WH. Global health sector strategy on HIV 2016-2021. Towards ending AIDS. Geneva: World Health Organization; 2016.
WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection 2016 [updated JUNE 2016; cited 2019 13/06/2019].
UNAIDs. 90–90–90 An ambitious treatment target to help end the AIDS epidemic. 2014.
Fox MP, Berhanu R, Steegen K, Firnhaber C, Ive P, Spencer D, et al. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa. Trop Med Int Health. 2016;21(9):1131–7.
Fox M, Berhanu R, Steegen K, Firnhaber C, Ive P, Spencer D, et al. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa; 2016.
Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Internal Med. 2000;133(1):21–30.
Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens GJ. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Internal Med. 2007;146(8):564–73.
WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach: World Health Organization, Geneva; 2016.
Granich R, Gupta S, Wollmers M, Ruffner M, Williams B. Modeling the HIV epidemic: why the 95–95–95 target and ART effectiveness parameters matter. Int J Virol AIDS. 2018;5:1.
Nasuuna E, Kigozi J, Babirye L, Muganzi A, Sewankambo NK, Nakanjako D. Low HIV viral suppression rates following the intensive adherence counseling (IAC) program for children and adolescents with viral failure in public health facilities in Uganda. BMC Public Health. 2018;18(1):1–9.
Byrd KK, Hou JG, Hazen R, Kirkham H, Suzuki S, Clay PG, et al. Antiretroviral adherence level necessary for HIV viral suppression using real-world data. JAIDS J Acquir Immune Defic Syndr. 2019;82(3):245–51.
World Health O. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. World Health Organization, Geneva; 2016.
Bvochora T, Satyanarayana S, Takarinda KC, Bara H, Chonzi P, Komtenza B, et al. Enhanced adherence counselling and viral load suppression in HIV seropositive patients with an initial high viral load in Harare, Zimbabwe: operational issues. PLoS ONE. 2019;14(2):e0211326.
Kacanek D, Yanling HUO, Malee K, Mellins CA, Smith R, Garvie PA, et al. Nonadherence and unsuppressed viral load across adolescence among US youth with perinatally acquired HIV. AIDS (London, England). 2019;33(12):1923.
MoH. Consolidated guidelines for prevention and treatment of HIV in UGANDA. In: Health Mo, editor. 2016. p. 154.
MoH. Consolidated guidelines for prevention and treatment of HIV in UGANDA. In: Health Mo, editor. Uganda; 2018.
MoH. Consolidated guidelines for prevention and treatment of HIV in Uganda. 2016.
McPherson-Baker S, Malow RM, Penedo F, Jones DL, Schneiderman N, Klimas NG. Enhancing adherence to combination antiretroviral therapy in non-adherent HIV-positive men. AIDS Care. 2000;12(4):399–404.
Bonner K, Mezochow A, Roberts T, Ford N, Cohn J. Viral load monitoring as a tool to reinforce adherence: a systematic review. JAIDS. 2013;64(1):74–8.
Jobanputra K, Parker LA, Azih C, Okello V, Maphalala G, Kershberger B, et al. Factors associated with virological failure and suppression after enhanced adherence counselling, in children, adolescents and adults on antiretroviral therapy for HIV in Swaziland. PLoS ONE. 2015;10(2):e0116144.
UAC. ‘2014 Uganda HIV and AIDS Country Progress Report’. 2015.
Reimers TM, Wacker DP, Koeppl G. Acceptability of behavioral interventions: a review of the literature. Sch Psychol Rev. 1987;16(2):212–27.
Marotta C, Lochoro P, Pizzol D, Putoto G, Mazzucco W, Saracino A, et al. Capacity assessment for provision of quality sexual reproductive health and HIV-integrated services in Karamoja, Uganda. Afr Health Sci. 2020;20(3):1053–65.
Gusdal AK, Obua C, Andualem T, Wahlström R, Tomson G, Peterson S, et al. Voices on adherence to ART in Ethiopia and Uganda: a matter of choice or simply not an option? AIDS Care. 2009;21(11):1381–7.
Odokonyero T, Mwesigye F, Adong A, Mbowa S. Universal Health Coverage in Uganda: the critical health infrastructure, healthcare coverage and equity. 2017.
Biadgilign S, Reda AA, Deribew A, Amberbir A, Belachew T, Tiyou A, et al. Knowledge and attitudes of caregivers of HIV-infected children toward antiretroviral treatment in Ethiopia. Patient Educ Counsel. 2011;85(2):e89–94.
Skovdal M, Campbell C, Nhongo K, Nyamukapa C, Gregson SJT. Contextual and psychosocial influences on antiretroviral therapy adherence in rural Zimbabwe: towards a systematic framework for programme planners. Int J Health Plan Manage. 2011;26(3):296–318.
Global HJGU. AIDS statistics—2018 fact sheet. 2019.
Ministry of Health U. Consolidated guidelines for prevention and treatment of HIV in Uganda. 2016.
Ministry of Health U. Annual health sector performamnce report, financial 2017/2018. 2018.
Ministry of Health U. Consolidated guidelines for prevention and treatment of HIV in Uganda. 2020.
Whitley E, Ball J. Statistics review 4: sample size calculations. Crit Care. 2002;6(4):1–7.
Durlak JA. How to select, calculate, and interpret effect sizes. J Pediatr Psychol. 2009;34(9):917–28.
Tola K, Abebe H, Gebremariam Y, Jikamo B. Improving completeness of inpatient medical records in Menelik II Referral Hospital, Addis Ababa. Ethiopia Adv Public Health. 2017;2017:8389414.
Malterud K, Siersma VD, Guassora ADJ. Sample size in qualitative interview studies: guided by information power. Q Health Res. 2016;26(13):1753–60.
Walker JL. Research column. The use of saturation in qualitative research. Can J Cardiovasc Nurs. 2012;22:2.
Attride-Stirling J. Thematic networks: an analytic tool for qualitative research. Qual Res. 2001;1(3):385–405.
Ritchie J, Spencer L. Qualitative data analysis for applied policy research. BMJ. 1994;1994(320):173–94.
Bekhet AK, Zauszniewski JA. Methodological triangulation: an approach to understanding data. Nurse Res. 2012.
Nasuuna E, Kigozi J, Babirye L, Muganzi A, Sewankambo NK, Nakanjako D. Low HIV viral suppression rates following the intensive adherence counseling (IAC) program for children and adolescents with viral failure in public health facilities in Uganda. BMC Public Health. 2018;18(1):1048.
Shuter J, Sarlo JA, Kanmaz TJ, Rode RA, Zingman BS. HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. J AIDS. 2007;45(1):4–8.
Lawn SD, Badri M, Wood R. Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS. 2005;19(18):2109–16.
Mutumba M, Musiime V, Lepkwoski JM, Harper GW, Snow RC, Resnicow K, et al. Examining the relationship between psychological distress and adherence to anti-retroviral therapy among Ugandan adolescents living with HIV. AIDS Care. 2016;28(7):807–15.
Cluver L, Shenderovich Y, Toska E, Rudgard WE, Zhou S, Orkin M, et al. Clinic and care: associations with adolescent antiretroviral therapy adherence in a prospective cohort in South Africa. AIDS (London, England). 2021;35(8):1263–71.
Bircher RE, Ntamatungiro AJ, Glass TR, Mnzava D, Nyuri A, Mapesi H, et al. High failure rates of protease inhibitor-based antiretroviral treatment in rural Tanzania—a prospective cohort study. PLoS ONE. 2020;15(1):e0227600.
Kacanek D, Huo Y, Malee K, Mellins CA, Smith R, Garvie PA, et al. Nonadherence and unsuppressed viral load across adolescence among US youth with perinatally acquired HIV. AIDS (London, England). 2019;33(12):1923–34.
Garone D, Conradie K, Patten G, Cornell M, Goemaere E, Kunene J, et al. High rate of virological re-suppression among patients failing second-line antiretroviral therapy following enhanced adherence support: a model of care in Khayelitsha, South Africa. S Afr J HIV Med. 2013;14(4):170–5.
Fox MP, Berhanu R, Steegen K, Firnhaber C, Ive P, Spencer D, et al. Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South Africa. S Afr J HIV Med. 2016;21(9):1131–7.
Kangwende R, Chirenda J, Mudyiradima R. HIV status disclosure among people living with HIV/AIDS at FASO, Mutare, Zimbabwe. 2009.
Chemaitelly H, Shelton JD, Hallett TB, Abu-Raddad LJ. Only a fraction of new HIV infections occur within identifiable stable discordant couples in sub-Saharan Africa. AIDS. 2013;27(2):251–60.
Bajunirwe F, Arts EJ, Tisch DJ, King CH, Debanne SM, Sethi AK. Adherence and treatment response among HIV-1-infected adults receiving antiretroviral therapy in a rural government hospital in Southwestern Uganda. J Int Assoc Phys AIDS Care. 2009;8(2):139–47.
Reda AA, Biadgilign S. Determinants of adherence to antiretroviral therapy among HIV-infected patients in Africa. AIDS Res Treat. 2012;12:574656.
Kalichman SC, Grebler TJ. Stress and poverty predictors of treatment adherence among people with low-literacy living with HIV/AIDS. Psychosomatic Med. 2010;72(8):810.
Kalichman SC, Hernandez D, Cherry C, Kalichman MO, Washington C, Grebler TJ. Food insecurity and other poverty indicators among people living with HIV/AIDS: effects on treatment and health outcomes. J Commun Health. 2014;39(6):1133–9.
Nachega JB, Knowlton AR, Deluca A, Schoeman JH, Watkinson L, Efron A, et al. Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults: a qualitative study. J AIDS. 2006;43:S127–33.
Adeniyi OV, Ajayi AI, Ter Goon D, Owolabi EO, Eboh A, Lambert JJ. Factors affecting adherence to antiretroviral therapy among pregnant women in the Eastern Cape, South Africa. BMC Infect Dis. 2018;18(1):175.
Musumari PM, Feldman MD, Techasrivichien T, Wouters E, Ono-Kihara M, Kihara MJ. “If I have nothing to eat, I get angry and push the pills bottle away from me”: a qualitative study of patient determinants of adherence to antiretroviral therapy in the Democratic Republic of Congo. AIDS Care. 2013;25(10):1271–7.
Leddy AM, Weiss E, Yam E, Pulerwitz JJB. Gender-based violence and engagement in biomedical HIV prevention, care and treatment: a scoping review. BMC Public Health. 2019;19(1):897.
Malow R, Dévieux JG, Stein JA, Rosenberg R, Jean-Gilles M, Attonito J, et al. Depression, substance abuse and other contextual predictors of adherence to antiretroviral therapy (ART) among Haitians. AIDS Behav. 2013;17(4):1221–30.
Kim MH, Zhou A, Mazenga A, Ahmed S, Markham C, Zomba G, et al. Why did I stop? Barriers and facilitators to uptake and adherence to ART in Option B+ HIV care in Lilongwe, Malawi. PLoS ONE. 2016;11(2):e0149527.
Hatcher AM, Smout EM, Turan JM, Christofides N, Stoeckl HJA. Intimate partner violence and engagement in HIV care and treatment among women: a systematic review and meta-analysis. AIDS. 2015;29(16):2183–94.
Nachega JB, Mills EJ, Schechter MJ. Antiretroviral therapy adherence and retention in care in middle-income and low-income countries: current status of knowledge and research priorities. AIDS. 2010;5(1):70–7.
Nasuuna E, Kigozi J, Muwanguzi PA, Babirye J, Kiwala L, Muganzi A, et al. Challenges faced by caregivers of virally non-suppressed children on the intensive adherence counselling program in Uganda: a qualitative study. BMC Health Serv Res. 2019;19(1):150.
Sabaté E, Sabaté E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
Soto TA, Bell J, Pillen M, for the HIV/AIDS Treatment Adherence HO, care CSGJA. Literature on integrated HIV care: a review. AIDS. 2004;16(sup1):43–55.
Zihindula G, John RA, Gumede DM, Gavin MR. A review on the contributions of NGOs in addressing the shortage of healthcare professionals in rural South Africa. Cogent Soc Sci. 2019;5(1):1674100.
Jewell BL, Smith JA, Hallett TB. Understanding the impact of interruptions to HIV services during the COVID-19 pandemic: a modelling study. EClinicalMedicine. 2020;26:100483.
Nagendra G, Carnevale C, Neu N, Cohall A, Zucker J. The potential impact and availability of sexual health services during the COVID-19 pandemic. Sex Transm Dis. 2020;47(7):434–6.
Jiang H, Zhou Y, Tang W. Maintaining HIV care during the COVID-19 pandemic. Lancet HIV. 2020;7(5):e308–9.
Karwa R, Maina M, Mercer T, Njuguna B, Wachira J, Ngetich C, et al. Leveraging peer-based support to facilitate HIV care in Kenya. PLoS Med. 2017;14(7):e1002355.
Grimsrud AT, Pike C, Bekker L-G. The power of peers and community in the continuum of HIV care. Lancet Glob Health. 2020;8(2):e167–8.
Peterson JL, Rintamaki LS, Brashers DE, Goldsmith DJ, Neidig JL. The forms and functions of peer social support for people living with HIV. J Assoc Nurses AIDS Care. 2012;23(4):294–305.
Harris GE, Larsen D. HIV peer counseling and the development of hope: perspectives from peer counselors and peer counseling recipients. AIDS Patient Care STDS. 2007;21(11):843–60.
Ross C. The effect of peer counselors on breastfeeding rates in the neonatal intensive care unit. Breastfeed Rev. 2007;15(2):33–4.
Genberg BL, Shangani S, Sabatino K, Rachlis B, Wachira J, Braitstein P, et al. Improving engagement in the HIV care cascade: a systematic review of interventions involving people living with HIV/AIDS as peers. AIDS Behav. 2016;20(10):2452–63.
Eaton AD, Carusone SC, Ceranto A, Craig SL, Busch A, McCullagh JW. Training peers to ease hospital discharge: a community-clinical partnership in complex HIV care. Progr Commun Health Partnersh. 2021;15(2):225–60.
Cabral HJ, Davis-Plourde K, Sarango M, Fox J, Palmisano J, Rajabiun S. Peer support and the HIV continuum of care: results from a multi-site randomized clinical trial in three urban clinics in the United States. AIDS Behav. 2018;22(8):2627–39.
Amico KR. Standard of care for antiretroviral therapy adherence and retention in care from the perspective of care providers attending the 5th international conference on HIV treatment adherence. J Int Assoc Phys AIDS Care. 2011;10(5):291–6.